Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can COVID-19 be a sexually transmitted disease? Posterity will judge.
Gaspari V, Lanzoni A, Patrizi A, Orioni G, Viviani F, Bardazzi F. Gaspari V, et al. Among authors: viviani f. Dermatol Ther. 2020 Jul;33(4):e13676. doi: 10.1111/dth.13676. Epub 2020 Jun 19. Dermatol Ther. 2020. PMID: 32447826 Free PMC article. No abstract available.
Does COVID-19 influence sexual behaviors?
Gaspari V, Orioni G, Viviani F, Raone B, Lanzoni A, Bardazzi F. Gaspari V, et al. Among authors: viviani f. Dermatol Ther. 2020 Nov;33(6):e14004. doi: 10.1111/dth.14004. Epub 2020 Jul 28. Dermatol Ther. 2020. PMID: 32654248 Free PMC article. No abstract available.
Psoriasis or sexually transmitted diseases?
Bardazzi F, Viviani F, DI Altobrando A, Merli Y, Gaspari V, Patrizi A. Bardazzi F, et al. Among authors: viviani f. Ital J Dermatol Venerol. 2022 Jun;157(3):293-294. doi: 10.23736/S2784-8671.21.07080-8. Epub 2021 Jul 20. Ital J Dermatol Venerol. 2022. PMID: 34282870 No abstract available.
The legs: An underestimated difficult-to-treat area of psoriasis.
Bardazzi F, Viviani F, Filippi F, Carpanese MA, Piraccini BM, Abbenante D. Bardazzi F, et al. Among authors: viviani f. Dermatol Ther. 2022 Jun;35(6):e15485. doi: 10.1111/dth.15485. Epub 2022 Apr 7. Dermatol Ther. 2022. PMID: 35383406 No abstract available.
Therapeutic approaches and targets for treatment of autoimmune bullous diseases.
Bardazzi F, Loi C, Chessa Marco A, Di Altobrando A, Filippi F, Lacava R, Viviani F, Balestri R, Leuzzi M, Sacchelli L. Bardazzi F, et al. Among authors: viviani f. Dermatol Ther. 2021 Sep;34(5):e15032. doi: 10.1111/dth.15032. Epub 2021 Jul 14. Dermatol Ther. 2021. PMID: 34145701 Review.
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.
Malagnino V, Cerva C, Cingolani A, Ceccherini-Silberstein F, Vergori A, Cuomo G, Perno CF, Puoti M, d'Arminio Monforte A, Cozzi-Lepri A, Andreoni M, Sarmati L; ICONA Foundation Study Group. Malagnino V, et al. Open Forum Infect Dis. 2020 Nov 18;8(1):ofaa566. doi: 10.1093/ofid/ofaa566. eCollection 2021 Jan. Open Forum Infect Dis. 2020. PMID: 33447635 Free PMC article.
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort.
Bandera A, Lorenzini P, Taramasso L, Cozzi-Lepri A, Lapadula G, Mussini C, Saracino A, Ceccherini-Silberstein F, Puoti M, Quiros-Roldan E, Montagnani F, Antinori A, d'Arminio Monforte A, Gori A; Icona Foundation Cohort. Bandera A, et al. J Viral Hepat. 2021 May;28(5):779-786. doi: 10.1111/jvh.13488. Epub 2021 Mar 11. J Viral Hepat. 2021. PMID: 33600068
71 results